|
NAB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.522800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.487400E-01 |
| Normal-vs-Stage2 |
4.978800E-01 |
| Normal-vs-Stage3 |
8.519600E-01 |
| Normal-vs-Stage4 |
8.357000E-01 |
| Stage1-vs-Stage2 |
1.052170E-01 |
| Stage1-vs-Stage3 |
1.637440E-01 |
| Stage1-vs-Stage4 |
1.888810E-01 |
| Stage2-vs-Stage3 |
5.643800E-01 |
| Stage2-vs-Stage4 |
6.189200E-01 |
| Stage3-vs-Stage4 |
9.732000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.017000E-01 |
| Normal-vs-AfricanAmerican |
1.944560E-01 |
| Normal-vs-Asian |
2.776800E-01 |
| Caucasian-vs-AfricanAmerican |
1.537790E-01 |
| Caucasian-vs-Asian |
4.737000E-01 |
| AfricanAmerican-vs-Asian |
4.951000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.192200E-01 |
| Normal-vs-Female |
3.453000E-01 |
| Male-vs-Female |
1.289180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.139440E-01 |
| Normal-vs-Age(41-60Yrs) |
6.548600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.399000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.907600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.751410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.679800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.096400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.295790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.973400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.759600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.413900E-02 |
| Classical-VS-Follicular |
2.02519999999984E-05 |
| Classical-VS-Other |
5.825000E-01 |
| Classical-VS-Normal |
5.433900E-02 |
| Tall-VS-Follicular |
3.818200E-01 |
| Tall-VS-Other |
6.695400E-01 |
| Tall-VS-Normal |
5.626200E-01 |
| Follicular-VS-Other |
4.055000E-01 |
| Follicular-VS-Normal |
6.880200E-02 |
| Other-VS-Normal |
8.975200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.382800E-01 |
| Normal-vs-N1 |
5.229400E-01 |
| N0-vs-N1 |
2.546000E-01 |
|
|
